Evidence map›Paper›PMID 41654763›Full record

ArticleBMC microbiology2026

Phenotypic and genomic characterization of three lytic bacteriophages against MDR Escherichia coli from livestock in India.

Anjay, Purushottam Kaushik, Awadhesh Prajapati, Rohit Kumar Jaiswal, Bhoomika, Seuli Saha Roy, Ajeet Kumar, Sudha Kumari, Archana, Baleshwari Dixit

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

AnjayDepartment of Veterinary Public Health and Epidemiology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India. dranjayvet@gmail.com.
Purushottam KaushikDepartment of Veterinary Public Health and Epidemiology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
Awadhesh PrajapatiDepartment of Veterinary Microbiology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
Rohit Kumar JaiswalDepartment of Livestock Products Technology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
BhoomikaDepartment of Veterinary Public Health and Epidemiology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
Seuli Saha RoyDepartment of Veterinary Public Health and Epidemiology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
Ajeet KumarDepartment of Veterinary Biochemistry, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
Sudha KumariDepartment of Veterinary Microbiology, Bihar Veterinary College, Bihar Animal Sciences University, Patna, India.
ArchanaDepartment of Veterinary Public Health and Epidemiology, College of Veterinary and Animal Sciences, Bihar Animal Sciences University, Kishanganj, Patna, India.
Baleshwari DixitDepartment of Veterinary Public Health and Epidemiology, College of Veterinary Science & Animal Husbandry, Rewa, India.

Funding

Bihar Animal Sciences University, Patna 02/DR/BASU/2019/799
6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) in Escherichia coli, particularly among animal-derived isolates, poses a major threat to public and veterinary health. With conventional antibiotics becoming increasingly ineffective against multidrug-resistant (MDR) strains, alternative solutions are urgently needed. Lytic bacteriophages, known for their host specificity and potent antibacterial activity, are promising therapeutic options. However, limited genomic data on phages from diverse ecological contexts hinder a comprehensive understanding of their diversity and functional potential.

methodsThis study aimed to isolate, characterize, and assess the therapeutic potential of lytic bacteriophages targeting MDR E. coli isolated from livestock. Phages were enriched from the sewage samples using an MDR E. coli host. Plaque morphology was assessed for lytic characteristics, and Transmission Electron Microscopy (TEM) was used for morphological identification. The thermal and pH stabilities were assessed under controlled incubation conditions. The host range was determined using 20 MDR E. coli strains from cattle, buffalo, and goats. One-step growth experiments were performed to determine the latent period and burst size of the phages. Whole-genome sequencing and annotation were performed to determine the genetic features, taxonomic classification, safety, and phylogenetic relationships.

resultsThree lytic Escherichia phage BASUE2, BASUE7, and BASUE10, were isolated, producing clear plaques indicative of strong lytic activity. All phages remained viable between 25 °C and 42°C and within pH 6–9, but were inactivated at 80°C and at highly acidic or alkaline conditions. BASUE7 exhibited the broadest host range, lysing 75% of MDR E. coli isolates, followed by BASUE2 (65%) and BASUE10 (55%), while none of the phages were active against K. pneumoniae, S. aureus, or Salmonella spp. Genome analysis revealed double-stranded DNA genomes of approximately 157 kb (BASUE2), 50 kb (BASUE7), and 48 kb (BASUE10), with G + C contents ranging from 44.62% to 45.47%. Taxonomically, BASUE2 was classified under Ackermannviridae, whereas BASUE7 and BASUE10 belonged to Siphoviridae, all within Caudovirales. All phages were predicted to be strictly lytic and lacked genes associated with lysogeny, antibiotic resistance, or virulence. Phylogenetic analysis revealed a distinct cluster of BASUE2, suggesting a divergent evolutionary origin from BASUE7 and BASUE10.

conclusionThis study presents the isolation of genetically safe, environmentally stable, and broadly active lytic phages effective against MDR E. coli of animal origin. These findings highlight the potential of these phages for use in veterinary therapy. However, further in vivo validation and development of phage cocktails are necessary to advance their clinical applications.

Indexed as

BacteriophagesColiphagesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsLivestockAnimalsBuffaloesCattleGenome, ViralGenomicsGoatsHost SpecificityIndiaPhenotypePhylogenySewageMultidrug-resistant Escherichia coliPhage genome analysisPhage therapyVeterinary pathogens

Identifiers

PMID41654763
PMCPMC12977953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.